Hamamatsu Photonics K.k. · TSE:6965
Hamamatsu Photonics K.k — Q2 FY2020 Earnings Presentation
35 slides from Hamamatsu Photonics K.k's earnings presentation, May 2020
Slide 1: Fiscal Year ending September 30, 2020 Second Quarter Report
Fiscal Year ending September 30, 2020 Second Quarter Report Hamamatsu Photonics K.K. Stock code 6965 May, 2020 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 1
Slide 2: Notes
Notes This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. This material includes
Slide 3: 1. Summary of 1st half results 2. Annual forecast
1. Summary of 1st half results 2. Annual forecast 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 3
Slide 4: Summary of 1st half financial results
Summary of 1st half financial results Net sales are 72.9 billion yen (down by 1.9% or -1.4 billion yen from last year). Sales in Medical-bio instrument field increased mainly for radiation inspection instrument, but overall sales declined due to the strong yen and delayed recovery in Industrial in
Slide 5: Consolidated 1st half financial results
Consolidated 1st half financial results (Unit : Million Yen) Increase in Medical-bio instrument Compared with prev. year …Market expansion mainly for dental, steady FY2019 FY2020 1st half 1st half Amount of Change rate demand for X-ray CT change Decrease in Industry instrument Net sales 74,413 72,97
Slide 6: Analysis of operating profit from 1st half of FY2019 to 1st half of FY2020
Analysis of operating profit from 1st half of FY2019 to 1st half of FY2020 (Unit : Million Yen) 18,000 *Excluding currency exchange effect Amount due to Change of SG Decrease of gross profit Impact by 16,000 change in gross & A and R & D by sales decrease currency profit ratio expenses fluctuation (
Slide 7: Sales by industry & application
Sales by industry & application In addition to steady sales of dental, Global downhold of capital investment Decreased in oil well logging X-ray CT and PET etc. also increased continued. Decreased in semiconductor and FA. due to crude oil price down. steadily. There are some advance Non-destructive
Slide 8: Consolidated financial results by business segment
Consolidated financial results by business segment (Unit : Million Yen) FY2019 FY2020 Amount of change Segment Account item Summary 1st half 1st half / percent change (1,374) Industrial instrument decreased. Net sales 30,000 28,626 …Laser dicing decreased due to inventory adjustment. (4.6%) Medical-
Slide 9: Sales by region
Sales by region Europe Asia and China Japan North America FY2019 23.5％ 22.8％ 29.1％ 24.3％ 1st st half FY2020 1st half 23.1％ 24.6％ 26.8％ 25.3％ (Unit : Million Yen) Europe Asia and China Japan North America FY2019 1st half 17,488 16,930 21,632 18,062 FY2020 1st half 16,879 17,967 19,556 18,472 Amount o
Slide 10: 1. Summary of 1st half results 2. Annual forecast
1. Summary of 1st half results 2. Annual forecast 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 10
Slide 11: Summary of FY2020 annual forecast
Summary of FY2020 annual forecast Sales was expected to recover in industrial instrument from second half of FY2020, however annual forecast has downwardly revised because of delayed industrial recovery. Consolidated net sales projection is 147.6 billion yen (up by 1.2% or +1.6 billion yen year-
Slide 12: Sales & profit through FY2022
Sales & profit through FY2022 Sales (Unit : Million Yen) Profit 180,000 40,000 160,000 35,000 140,000 30,000 120,000 25,000 100,000 20,000 80,000 15,000 60,000 40,000 10,000 20,000 5,000 0 0 FY2020 FY2020 FY2021 FY2022 FY2018 FY2019 (Forecast) (Original plan) (Plan) (Plan) Net sales (left) 144,338 1
Slide 13: FY2020 annual forecast (comparison with original plan)
FY2020 annual forecast (comparison with original plan) (Unit : Million Yen) FY2020 From original plan FY2020 Industrial instrument is expected to increase. (Original Amount of Change (Forecast) …Considering recovery from downhold of capital plan) change rate investment is delayed than expected Net s
Slide 14: FY2020 annual forecast (comparison with previous year)
FY2020 annual forecast (comparison with previous year) (Unit : Million Yen) From previous year Medical-bio instrument is expected to increase. FY2019 FY2020 result (Forecast) Amount of Change …Expects continuous market expansion of mainly change rate radiation inspection equipment. Net sales 145,912
Slide 15: Sales forecast by industry & application (comparison with original plan)
Sales forecast by industry & application (comparison with original plan) Increase in radiation inspection Recovery from downhold of capital Big decrease in oil well logging due to instrument than expected, but investment is delayed, and sharp drop in crude oil prices. laboratory testing to decrease.
Slide 16: Sales forecast by industry & application (comparison with previous year)
Sales forecast by industry & application (comparison with previous year) X-ray CT, PET and dental to be strong. Semiconductor to show tendency Decrease in oil well logging due to Dental to slow down as a reaction of the for recovery. FA instrument seems price drop of crude oil. first half. to have b
Slide 17: Consolidated financial forecast by business segment
Consolidated financial forecast by business segment (Unit : Million Yen) FY2019 FY2020 FY2020 comparison with comparison with Segment Account item Factors for changing the forecast result (Original plan) (Forecast) previous year original plan (1,593) (750) Medical-bio instrument is expected to incre
Slide 18: Impacts of the novel coronavirus infection (COVID-19)
Impacts of the novel coronavirus infection (COVID-19) • There are many uncertainties regarding impacts of the coronavirus. Therefore, our forecast of considered financial results for the FY2020 does not include the impacts of the coronavirus. • Due to the following factors, we anticipate the potenti
Slide 19: Global offices and group companies
Asia North America HAMAMATSU PHOTONICS K.K. HAMAMATSU CORPORATION Headquarters Main Office / California Office / Chicago Office HAMAMATSU PHOTONICS (CHINA)Co., Ltd. / Boston Office Head Office / Shanghai Branch / Shenzhen Branch PHOTONICS MANAGEMENT Corp. BEIJING HAMAMATSU PHOTON TECHNIQUES INC. ENE
Slide 20: 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved.
🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 20
Slide 21: Second Quarter of Fiscal Year ending September 30, 2020 Databook
Second Quarter of Fiscal Year ending September 30, 2020 Databook Hamamatsu Photonics K.K. Tokyo Stock Exchange : 6965 5.15. 2020 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 21
Slide 22: Notes
Notes This material is not intended to be a solicitation to buy or sell any securities of Hamamatsu Photonics K.K. The information contained in this material is based on data available as of making it. No guarantees, promises are made as to its accuracy or completeness. This material includes
Slide 23: Consolidated income statements
Consolidated income statements (Unit : Million Yen) FY2018 FY2019 FY2020 2nd half Year Year ％ 1st half 2nd half Year ％ 1st half ％ (Forecast) (Forecast) Net sales 144,338 100.0 74,413 71,499 145,912 100.0 72,975 74,625 147,600 100.0 Cost of sales 70,385 48.8 36,255 35,661 71,916 49.3 36,768 37,532 74
Slide 24: Consolidated sales by industry
Consolidated sales by industry (Unit : Million Yen) FY2018 FY2019 FY2020 Application nd 2 half Year Year ％ 1st half 2nd half Year ％ 1st half % (Forecast) (Forecast) Radiographic testing 37,737 26.1 20,409 20,432 40,841 28.0 22,366 21,526 43,892 29.7 Medical-bio Laboratory testing 12,863 8.9 7,239 7,
Slide 25: Sales by industry & application Electron tube segment
Sales by industry & application Electron tube segment (Unit : Million Yen) FY2018 FY2019 FY2020 Application nd 2 half Year Year ％ 1st half 2nd half Year ％ 1st half % (Forecast) (Forecast) Radiographic testing 11,326 19.6 5,970 5,269 11,239 18.9 5,874 5,313 11,188 19.3 Medical-bio Laboratory testing
Slide 26: Sales by industry & application Opto-semiconductor segment
Sales by industry & application Opto-semiconductor segment (Unit : Million Yen) FY2018 FY2019 FY2020 Application nd 2 half Year Year ％ 1st half 2nd half Year ％ 1st half % (Forecast) (Forecast) Radiographic testing 26,335 39.0 14,405 15,159 29,564 44.8 16,481 16,210 32,691 46.6 Medical-bio Laboratory
Slide 27: Sales by industry & application Imaging and measurement instruments segment
Sales by industry & application Imaging and measurement instruments segment (Unit : Million Yen) FY2018 FY2019 FY2020 Application nd 2 half Year Year ％ 1st half 2nd half Year ％ 1st half % (Forecast) (Forecast) Radiographic testing 6 0.0 0 3 3 0.0 7 0 7 0.0 Medical-bio Laboratory testing 3,404 19.8 1
Slide 28: Major subsidiaries income statements (The U.S., Germany, China)
Major subsidiaries income statements (The U.S., Germany, China) Local currency (thousand dollar) Yen (million yen) Account FY2019 FY2020 FY2019 FY2020 Company item st nd st 2nd half Year st nd st 2nd half Year 1 half ％ 2 half ％ Year ％ 1 half ％ ％ (Forecast) ％ 1 half 2 half Year 1 half (Forecast) (For
Slide 29: Consolidated financial forecast by business segment
Consolidated financial forecast by business segment (Unit : Million Yen) FY2018 FY2019 FY2020 Segment 2nd half Year Year 1st half 2nd half Year 1st half (Forecast) (Forecast) Electron tube 57,781 30,000 29,593 59,593 28,626 29,373 58,000 Opto-semiconductor 67,494 34,018 31,988 66,006 35,219 34,980 7
Slide 30: Electron tube's consolidated performance
Electron tube's consolidated performance (Unit : Million Yen) FY2018 FY2019 FY2020 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 57,781 100.0 30,000 29,593 59,593 100.0 28,626 29,373 58,000 100.0 Cost of sales 25,341 43.9 12,811 12,680 25,491 42.8 12,082 12
Slide 31: Opto-semiconductor's consolidated performance
Opto-semiconductor's consolidated performance (Unit : Million Yen) FY2018 FY2019 FY2020 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 67,494 100.0 34,018 31,988 66,006 100.0 35,219 34,980 70,200 100.0 Cost of sales 35,368 52.4 18,108 17,805 35,913 54.4 19,8
Slide 32: Imaging and measurement instrument's consolidated performance
Imaging and measurement instrument's consolidated performance (Unit : Million Yen) FY2018 FY2019 FY2020 2nd half Year Year % 1st half 2nd half Year % 1st half % (Forecast) (Forecast) Net sales 17,169 100.0 9,296 9,116 18,412 100.0 8,110 9,539 17,650 100.0 Cost of sales 8,365 48.7 4,520 4,727 9,247 5
Slide 33: Consolidated capital investments, R & D expenses and depreciation
Consolidated capital investments, R & D expenses and depreciation (Unit : Million Yen) FY2015 FY2016 FY2017 FY2018 FY2019 FY2020 Ratio to Ratio to Ratio to Ratio to Ratio to Ratio to Amount Amount Amount Amount Amount Amount sales (%) sales (%) sales (%) sales (%) sales (%) sales (%) 1st quarter 3,1
Slide 34: High-energy physics experiments using photomultiplier tubes
High-energy physics experiments using photomultiplier tubes Expected year of Type Project name Purpose Place first delivery Number 40,000 Underground Hyper-Kamiokande Neutrino, Proton decay Japan 2021〜 7,000 Mediterranean KM3NeT Neutrino Sea 2020〜 175,000 Deep-sea Baikal-GVD Neutrino Russia 2015〜 10
Slide 35: 🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved.
🄫 Hamamatsu Photonics K.K. and its affiliates. All Rights Reserved. 35
Hamamatsu Photonics K.K. — Q2 FY2020 Earnings Presentation on 6ix